The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Journal: Evidence-based Cardiology. 2012;(4): 32‑38

Read: 4343 times

To cite this article:

. Evidence-based Cardiology. 2012;(4):32‑38. (In Russ.)

References:

  1. Marchioli R., Barzi F., Bomba E., et al.; GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002;105:1897-1903.
  2. Tavazzi L., Maggioni A.P., Marchioli R., et al.; GISSI-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1223-1230.
  3. Yokoyama M., Origasa H., Matsuzaki M., et al.; Japan EPA Lipid Intervention Study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369:1090-1098.
  4. KromhoutD., Giltay E.J., Geleijnse J.M.; Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010; 363:2015-2026.
  5. Bosch J., Gerstein H.C., Dagenais G.R., et al.; ORIGIN Trial Investigators. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012;367:309-318.
  6. Saravanan P., Davidson N.C., Schmidt E.B,. Calder P.C. Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010;376:540-550.
  7. Kris-Etherton P.M., Harris W.S., Appel L.J.; American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-2757.
  8. Van de Werf F., Bax J., Betriu A., et al; ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-2945.
  9. US Food and Drug Administration. http://www .fda.gov. Accessed August 20, 2012.
  10. Electronic Medicines Compendium (eMC). Available at: www.medicines.org.uk/emc/medicine/10312 /indications. Accessed August 20, 2012.
  11. Filion K.B., El Khoury F., Bielinski M., et al. Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 2010;10:24.
  12. Marik P.E., Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 2009;32:365-372.
  13. Zhao Y.T., Chen Q., Sun Y.X., et al. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann Med 2009;41:301-310.
  14. Hooper L., Thompson R.L., Harrison R.A., et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev 2004;(4):CD003177.
  15. Trikalinos T.A., Lee J., Moorthy D., et al. Effects of eicosapentanoic acid and docosahexanoic acid on mortality across diverse settings: systematic review and meta- analysis of randomized trials and prospective cohorts. http://www.ncbi.nlm.nih.gov/books/NBK91413/. Accessed August 20, 2012.
  16. Kwak S.M., Myung S.K., Lee Y.J., Seo H.G.; Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med 172:686-694.
  17. Higgins J.P., Altman D.G., Gøtzsche P.C., et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. et al.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
  18. Nilsen D.W., Albrektsen G., Landmark K., et al. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr 2001;74:50-56.
  19. von Schacky C., Angerer P., Kothny W., et al. The effect of dietary omega-3 fatty acids on coronary atherosclerosis: a randomized, double- blind, placebo-controlled trial. Ann Intern Med 1999;130:554-562.
  20. Leng G.C., Lee A.J., Fowkes F.G., et al. Randomized controlled trial of gammalinolenic acid and eicosapentaenoic acid in peripheral arterial disease. Clin Nutr 1998;17:265-271.
  21. Sacks F.M., Stone P.H., Gibson C.M., et al.; HARP Research Group. Controlled trial of fish oil for regression of human coronary atherosclerosis. J Am Coll Cardiol 1995;25:1492-1498.
  22. Singh R.B., Niaz M.A., Sharma J.P., et al. Randomized, double-blind, placebo- controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival 4. Cardiovasc Drugs Ther 1997;11:485-491.
  23. Galan P., Kesse-Guyot E., Czernichow S., et al.; SU.FOL.OM3 Collaborative Group. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010;341:c6273.
  24. Burr M.L., Ashfield-Watt P.A., Dunstan F.D., et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 2003;57:193-200.
  25. Burr M.L., Fehily A.M., Gilbert J.F., et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989;2:757-761.
  26. Svensson M., Schmidt E.B., Jørgensen K.A., Christensen J.H.; OPACH Study Group. N-3 fatty ac ids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol 2006;1:780-786.
  27. Raitt M.H., Connor W.E., Morris C., et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 2005; 293:2884-2891.
  28. Leaf A., Albert C.M., Josephson M., et al; Fatty Acid Antiarrhythmia Trial Investigators. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005;112:2762-2768.
  29. Brouwer I.A., Zock P.L., Camm A.J., et al; SOFA Study Group. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardio verter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 2006;295:2613-2619.
  30. Rauch B., Schiele R., Schneider S., et al; OMEGA Study Group. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 2010;122:2152-2159.
  31. Einvik G., Klemsdal T.O., Sandvik L., Hjerkinn E.M. A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk. Eur J Cardiovasc Prev Rehabil 2010;17:588-592.
  32. Garbagnati F., Cairella G., De Martino A., et al. Is antioxidant and n-3 supplementation able to improve functional status in poststroke patients? Results from the Nutristroke Trial. Cerebrovasc Dis 2009;27:375-383
  33. Bucher H.C., Hengstler P., Schindler C., Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112:298-304.
  34. Assmann G., Schulte H. Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study. Am J Cardiol 1992;70:10H-13H.
  35. Castelli W.P., Anderson K., Wilson P.W., Levy D. Lipids and risk of coronary heart disease: the Framingham Study. Ann Epidemiol 1992;2:23-28.
  36. Conroy R.M., Pyörälä K., Fitzgerald A.P., et al; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
  37. Podrid P.J., Myerburg R.J. Epidemiology and stratification of risk for sudden cardiac death. Clin Cardiol 2005;28 (suppl 1):I3-I11.
  38. Morris M.C., Sacks F., Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993;88:523-533.
  39. Guyatt G., Rennie D. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 2nd ed. Chicago, IL: American Medical Association; 2008.
  40. Lavie C.J., Milani R.V., Mehra M.R., Ventura H.O. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009;54:585-594.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.